
Description
CuriRx is a certified minority woman owned company with 13,000 sqft, well equipped facility, established in 2012 and located in the Wilmington, MA. With a combined experience of over 150 years, we offer high quality development services in complex formulation, analytical method development and testing, as well an end-to-end bioprocessing solution.
Type of Drugs Manufactured:
Small Molecule;Biologics;Cell & Gene Therapy
CDMO Services:
Drug Product Formulation (FDF);Research & Development;Analytical Development
Facilities Locations:
North America
Regulatory Approvals for facilities:
ISO
Manufacturing Technologies:
Cartridges;Inhalers;Liquids;Lyophilized amps/vials;Pre-Filled Syringes (PFS)
Capabilities
- Accelerated Stability Studies
- Analytical Services
- Bioprocessing
- Cell and Gene Therapy
- Cell Culture Media Development
- Chemistry (CMC)
- Clinical Dose
- Contract Development and Manufacturing (CDMO)
- Dosage Form Development
- Downstream Processing
- Drug Development
- Feasibility Studies
- Lyophilization
- Mammalian Cell Culture
- Mass Spectrometry
- Microbial Fermentation
- Photostability
- Preformulation
- Process Characterization
- Process Development
- Process Validation Studies
- Protein and Peptide
- Research & Development
Contact Information
AI and Digital Manufacturing Benchmarking Survey
Take this quick 5 minute assessment to benchmark your organisation’s digital and AI maturity — and see how you compare with industry peers.